Foreign body-type multinucleated giant cells induced by interleukin-4 express select lymphocyte co-stimulatory molecules and are phenotypically distinct from osteoclasts and dendritic cells

Experimental and Molecular Pathology

Volumn 91, Issue 3, 2011, Pages 673-681

  McNally, Amy K ^a   Anderson, James M ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biocompatibility; Chronic inflammation; Lymphocyte; Macrophage; Multinucleated giant cell

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CALCITONIN RECEPTOR; CD14 ANTIGEN; CD209 ANTIGEN; CD40 ANTIGEN; CD68 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CD98 ANTIGEN; FAS ANTIGEN; GLYCOPROTEIN P 15095; HLA DR ANTIGEN; INTERLEUKIN 4; PROGRAMMED DEATH 1 LIGAND 1; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; T6 ANTIGEN;

ARTICLE; BIOCOMPATIBILITY; CELL FUSION; CELL INTERACTION; CELL LYSATE; CELL STRUCTURE; CHRONIC INFLAMMATION; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; GIANT CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MACROPHAGE FUNCTION; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR PATHOLOGY; OSTEOCLAST; PHENOTYPE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ACID PHOSPHATASE; ANTIGENS, CD; B7 ANTIGENS; CELL ADHESION MOLECULES; CELL FUSION; DENDRITIC CELLS; GIANT CELLS, FOREIGN-BODY; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-4; ISOENZYMES; LECTINS, C-TYPE; MACROPHAGE ACTIVATION; MACROPHAGES; MONOCYTES; OSTEOCLASTS; RECEPTORS, CALCITONIN; RECEPTORS, CELL SURFACE;

EID: 80053542950     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2011.06.012     Document Type: Article

References (43)

1. Anderson J.M. Multinucleated giant cells. Curr. Opin. Hematol. 2000, 7:40-47.
2. Anderson J.M., McNally A.K. Biocompatibility of implants: lymphocyte/macrophage interactions. Semin. Immunopathol. 2011, 33:221-233.
3. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y., Pulendran B., Palucka K. Immunobiology of dendritic cells. Ann. Rev. Immunol. 2000, 18:767-811.
4. Boissy P., Machuca I., Pfaff M., Ficheux D., Jurdic P. Aggregation of mononucleated precursors triggers cell surface expression of alphavbeta3 integrin essential to formation of osteoclast-like multinucleated cells. J. Cell Sci. 1998, 111:2563-2574.
5. Boukour S., Masse J.M., Benit L., Dubart-Kupperschmidt A., Cramer E.M. Lentivirus degradation and DC-SIGN expression by human platelets and megakaryocytes. J. Thromb. Haemost. 2006, 4:426-435.
6. Brodbeck W.G., MacEwan M., Colton E., Meyerson H., Anderson J.M. Lymphocytes and the foreign body response: lymphocyte enhancement of macrophage adhesion and fusion. J. Biomed. Mater. Res. 2005, 74A:222-229.
7. Carreno B.M., Collins M. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Ann. Rev. Immunol. 2002, 20:29-53.
8. Chang D.T., Jones J.A., Meyerson H., Colton E., Kwon I.K., Matsuda T., Anderson J.M. Lymphocyte/macrophage interactions: biomaterial surface-dependent cytokine, chemokine, and matrix protein production. J. Biomed. Mater. Res. 2008, 87A:676-687.
9. Chang D.T., Colton E., Anderson J.M. Paracrine and juxtacrine lymphocyte enhancement of adherent macrophage and foreign body giant cell activation. J. Biomed. Mater. Res. 2008, 89A:490-498.
10. Chang D.T., Colton E., Matsuda T., Anderson J.M. Lymphocyte adhesion and interactions with biomaterial adherent macrophages and foreign body giant cells. J. Biomed. Mater. Res. 2009, 91A:1210-1220.
11. Clarkson M.R., Sayegh M.H. T cell costimulatory pathways in allograft rejection and tolerance. Transplantation 2005, 80:555-563.
12. DeFife K.M., Jenney C.R., McNally A.K., Colton E., Anderson J.M. Interleukin-13 induces monocyte macrophage fusion and mannose receptor expression. J. Immunol. 1997, 158:3385-3390.
13. DeFranco A.L., Weiss A. Lymphocyte activation and effector functions. Curr. Opin. Immunol. 1998, 10:243-267.
14. Fujikawa Y., Quinn J.M., Sabokbar A., McGee J.O., Althanasou N.A. The human osteoclast precursor circulates in the monocyte fraction. Endocrinology 1996, 137:4058-4060.
15. Giejtenbeek T.B., Torensma R., Van Vliet S.J., Van Duijnhoven G.C., Adema G.J., Van Kooyk Y., Figdor C.G. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000, 100:575-585.
16. Gottfried E., Kunz-Schughart L.A., Weber A., Rehli M., Peuker A., Muller A., Kastenberger M., Brockhoff G., Andreesen R., Kreutz M. Expression of CD68 in non-myeloid cell types. Scand. J. Immunol. 2009, 70:161-162.
17. Hayman A.R. Tartrate-resistant acid phosphatase (TRAP) and the osteoclast/immune cell dichotomy. Autoimmunity 2008, 41:218-223.
18. Hume D.A. Macrophages as APC and the dendritic cell myth. J. Immunol. 2008, 181:5829-5835.
19. Kao W.J., McNally A.K., Hiltner A., Anderson J.M. Role for interleukin-4 in foreign-body giant cell formation on a poly(etherurethane urea) in vivo. J. Biomed. Mater. Res. 1995, 29:1267-1275.
20. Khoury S.J., Sayegh M.H. The roles of new negative T cell co-stimulatory pathways in regulating autoimmunity. Immunity 2004, 20:529-538.
21. Kroczek R.A., Mages H.W., Hutloff A. Emerging paradigms of T-cell co-stimulation. Curr. Opin. Immunol. 2004, 16:321-327.
22. Lauener R.P., Goyer S.M., Geha R.S., Vercelli D. Interleukin-4 down-regulates the expression of CD14 in normal human monocytes. Eur. J. Immunol. 1990, 20:2375-2381.
23. Lechmann M., Berchtold S., Hauber J., Steinkasserer A. CD83 on dendritic cells: more than just a marker for maturation. Trends Immunol. 2002, 23:273-275.
24. MacEwan M.R., Brodbeck W.G., Matsuda T., Anderson J.M. Monocyte/lymphocyte interactions and the foreign body response: in vitro effects of biomaterial surface chemistry. J. Biomed. Mater. Res. 2005, 74A:285-293.
25. Martin-Orozco N., Dong C. New battlefields for co-stimulation. J. Exp. Med. 2006, 817-820.
26. McNally A.K., Anderson J.M. Interleukin-4 induces foreign body giant cells from human monocytes/macrophages. Differential lymphokine regulation of macrophage fusion leads to morphological variants of multinucleated giant cells. Am. J. Pathol. 1995, 147:1487-1499.
27. McNally A.K., Anderson J.M. β1 and β2 integrins mediate adhesion during macrophage fusion and multinucleated foreign body giant cell formation. Am. J. Pathol. 2002, 160:621-630.
28. McNally A.K., Anderson J.M. Foreign body-type multinucleated giant cell formation is potently induced by α-tocopherol and prevented by the diacylglycerol kinase inhibitor R59022. Am. J. Pathol. 2003, 163:1147-1156.
29. McNally A.K., Anderson J.M. Macrophage fusion and multinucleated giant cells of inflammation. Cell Fusion in Health and Disease, Advances in Experimental Medicine and Biology 2011, 97-111. Springer, New York. T. Dittmar, K.S. Zanker (Eds.).
30. McNally A.K., MacEwan S.R., Anderson J.M. α-subunit partners to β1 and β2 integrins during IL-4-induced foreign body giant cell formation. J. Biomed. Mater. Res. 2007, 82A:568-574.
31. McNally A.K., Jones J.A., MacEwan S.R., Colton E., Anderson J.M. Vitronectin is a critical protein adhesion substrate for IL-4-induced foreign body giant cell formation. J. Biomed. Mater. Res. 2008, 86A:535-543.
32. Miyamoto Y.J., Mitchell J.S., McIntyre B.W. Physical association and functional interaction between beta1 integrin and CD98 on human T lymphocytes. Mol. Immunol. 2003, 39:739-751.
33. Moreno J.L., Kaczmarek M., Keegan A.D., Tondravi M. IL-4 suppresses osteoclast development and mature osteoclast function by a STAT6-dependent mechanism: Irreversible inhibition of the differentiation program activated by RANKL. Blood 2003, 102:1078-1086.
34. Quinn J.M.W., Morfis M., Lam M.H.C., Elliot J., Kartsogiannis V., Williams E.D., Gillespie M.T., Martin T.J., Sexton P.M. Calcitonin receptor antibodies in the identification of osteoclasts. Bone 1999, 25:1-8.
35. Rodriguez A., Voskerician G., Meyerson H., MacEwan S., Anderson J.M. T cell subset distributions following primary and secondary implantation at subcutaneous biomaterial implant sites. J. Biomed. Mater. Res. 2008, 85A:556-565.
36. Romani N., Reider D., Heuer M., Ebner S., Kampgen E., Eibl B., Niederwieser D., Schuler G. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J. Immunol. Methods 1996, 96:137-151.
37. Santana M.A., Rosenstein Y. What it takes to become an effector T cell: the process, the cells involved, and the mechanisms. J. Cell. Physiol. 2003, 195:392-401.
38. Savina A., Amigorena S. Phagocytois and antigen presentation in dendritic cells. Immunol. Rev. 2007, 219:143-156.
39. Schuster M., Kocher A., Lietz K., Ankersmit J., John R., Edwards N., Oz M., Itescu S. Induction of CD40 ligand expression in human T cells by biomaterials derived from left ventricular assist device. Transplant. Proc. 2001, 33:1960-1961.
40. Strobl H., Scheinecker C., Csmarits B., Majdic O., Knapp W. Flow cytometric analysis of intracellular CD68 molecule expression in normal and malignant haemopoiesis. Immunobiol 1995, 90:774-782.
41. Teitelbaum S.L. Bone resorption by osteoclasts. Science 2000, 289:1504-1508.
42. Tzachanis D., Berezovskaya A., Nadler L.M., Boussiotis V.A. Blockade of B7/CD28 in mixed lymphocyte reaction cultures results in the generation of alternatively activated macrophages, which suppress T-cell responses. Blood 2001, 99. 1465-14.
43. Wang S., Chen L. T lymphocyte co-signaling pathways of the B7-CD28 family. Cell. Mol. Immunol. 2004, 1:37-42.